ARCHIVES

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

This article is from The Cancer Letter archive.

Vol. 16 No. 15 | April 13, 1990

Download PDF Visit The Full Archive

Related Articles

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

L.I. Center At Stony Brook’s Goal Is Comprehensive Status.

October 27, 2000

How the Institute Fared In House Markup: Chart

July 18, 1997

The Cancer Letter Provides Full Text Of Publications To University Of Kentucky.

October 19, 2001

Pathology In Operating Suite Cuts Need for More Surgery

February 24, 2012

Board of Scientific Advisors discussion: Are peer reviewers correctly interpreting the guidelines?

March 19, 2004